Schonfeld Strategic Advisors LLC - BLACK DIAMOND THERAPEUTICS I ownership

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 94 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q4 2021. The put-call ratio across all filers is 2.56 and the average weighting 0.0%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of BLACK DIAMOND THERAPEUTICS I
ValueSharesWeighting
Q3 2023$427,917
+1760.5%
149,100
+965.0%
0.00%
Q3 2022$23,000
-37.8%
14,000
-5.4%
0.00%
Q2 2022$37,000
-32.7%
14,800
-25.6%
0.00%
Q1 2022$55,000
-29.5%
19,900
+35.4%
0.00%
-100.0%
Q4 2021$78,000
-38.1%
14,700
-1.3%
0.00%0.0%
Q3 2021$126,000
-63.7%
14,900
-47.7%
0.00%
-75.0%
Q2 2021$347,000
-67.5%
28,500
-14.4%
0.00%
-71.4%
Q4 2020$1,068,000
+337.7%
33,313
+311.3%
0.01%
+180.0%
Q3 2020$244,0008,1000.01%
Other shareholders
BLACK DIAMOND THERAPEUTICS I shareholders Q4 2021
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 634,191$1,820,1282.14%
NEA Management Company, LLC 4,448,757$12,767,9330.99%
CHI Advisors LLC 720,000$2,066,4000.82%
Bellevue Group AG 8,135,839$23,349,8580.38%
Parkman Healthcare Partners LLC 520,587$1,494,0850.27%
Artal Group S.A. 2,046,517$5,8740.25%
RA Capital Management 3,525,754$10,118,9140.20%
Ikarian Capital, LLC 555,572$1,594,4920.19%
TANG CAPITAL MANAGEMENT LLC 400,000$1,148,0000.16%
Newtyn Management, LLC 205,000$588,3500.14%
View complete list of BLACK DIAMOND THERAPEUTICS I shareholders